WASHINGTON (AP) — The Food and Drug Administration said Tuesday it approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes. The agency cleared the company’s drug, ...
SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...
To date, there has been no real-world comparative data published on the initiation of injectable therapy with insulin glargine disposable pen (GLA-P) of glucagons-like peptide-1 agonist liraglutide ...
Research published Sunday evaluates the effectiveness of the active ingredient in injectable diabetes and obesity drugs when taken orally. By Dani Blum Reporting from the American Diabetes Association ...
Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according to the results of two international ...
- Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the only non-insulin, injectable diabetes treatment available in a pen with a no-see, no-handle needle INDIANAPOLIS, Nov. 25, 2014 ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Bydureon® Pen (exenatide extended-release for injectable ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NewsNation) — An estimated 15.5 million U.S ...
Ozempic, Wegovy and other GLP-1 medications have gained widespread popularity for weight loss and diabetes control in recent years — but the spike in demand has made it difficult for some people to ...
Whether you have a diagnosis or are curious about your options, this guide answers some of the most common questions about injectable medications for type 2 diabetes. Injectable medications, ...
Drugmaker Novo Nordisk’s newly approved oral diabetes treatment will cost $772 per month, according to Investor’s Business Daily. Called Rybelsus, the treatment’s monthly cost is similar, just ...
This transcript has been edited for clarity. Jay H. Shubrook, DO: Hi. I'm Jay Shubrook, a family physician and diabetologist at Touro University California in Vallejo. Today we're going to discuss the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback